|
Volumn 83, Issue 2, 2000, Pages 176-177
|
Cost-benefit analysis is the key
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GROWTH HORMONE;
SOMATOMEDIN C;
COST BENEFIT ANALYSIS;
DRUG COST;
DRUG EFFICACY;
DRUG INDICATION;
GROWTH HORMONE DEFICIENCY;
HORMONE SUBSTITUTION;
HUMAN;
PRIORITY JOURNAL;
SHORT SURVEY;
|
EID: 0033843669
PISSN: 00039888
EISSN: 14682044
Source Type: Journal
DOI: 10.1136/adc.83.2.176 Document Type: Short Survey |
Times cited : (3)
|
References (15)
|